Literature DB >> 25132286

The Ser680Asn polymorphism in the follicle-stimulating hormone receptor gene is associated with the ovarian response in controlled ovarian hyperstimulation.

Xianliang Huang1, Lu Li, Ling Hong, Weijin Zhou, Huijuan Shi, Huiqin Zhang, Zhaofeng Zhang, Xiaoxi Sun, Jing Du.   

Abstract

OBJECTIVE: Polymorphisms in the follicle-stimulating hormone receptor (FSHR) gene are reported to be associated with the ovarian response in controlled ovarian hyperstimulation (COH), although there remains some discordance between studies. Here, using the largest patient sample to date, we evaluated the association of the p.Ser680Asn (S(680)N) polymorphism in the FSHR gene with the outcome of COH.
DESIGN: Cohort study.
SETTING: Medical academy and hospital. PATIENTS: A total of 1250 infertile Chinese women undergoing IVF/ICIS-ET treatment were included. MEASURES: The association between an FSHR polymorphism (S(680)N) and the ovarian response was analysed. Genotyping was performed by utilizing direct sequencing and the Sequenom MassARRAY iPLEX platform. Follicular fluid oestradiol (E₂) and follicle-stimulating hormone (FSH) concentrations were determined using electrochemiluminesence immunoassays. The ovarian response parameters were analysed based on the FSHR genotypes. The odds ratios (ORs) and 95% confidence intervals (95% CIs) were calculated for the risk genotypes and alleles.
RESULTS: There were linear correlations between the basal FSH level, exogenous gonadotropin consumption, and oocytes retrieved and the Ser680 alleles. Patients in the homozygous SS group demonstrated higher basal FSH levels, required more dosage of exogenous gonadotropin for ovarian stimulation, and had fewer numbers of oocytes retrieved compared with patients in the homozygous NN and heterozygous groups. Logistic regression analysis revealed that the OR of a poor ovarian response for the NS genotype was 1·79 (95% CI 1·28-2·61; P < 0·001), whereas that for the SS genotype was 2·25 (95% CI 1·40-3·58; P < 0·001) after adjusting for age, BMI and basal FSH level. The concentration of E2 in the follicular fluid was significantly higher in subjects with the NN genotype than the SS genotype (772 ± 545 ng/ml vs. 1299 ± 504 ng/ml).
CONCLUSIONS: Follicle-stimulating hormone receptor gene polymorphism at position 680 is associated with different ovarian responses to controlled ovarian hyperstimulation.
© 2014 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25132286     DOI: 10.1111/cen.12573

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  12 in total

1.  Effect of follicle-stimulating hormone receptor Asn680Ser polymorphism on the outcomes of controlled ovarian hyperstimulation: an updated meta-analysis of 16 cohort studies.

Authors:  Huilin Tang; Yingying Yan; Tiansheng Wang; Ting Zhang; Weilong Shi; Rong Fan; Yao Yao; Suodi Zhai
Journal:  J Assist Reprod Genet       Date:  2015-10-19       Impact factor: 3.412

2.  The carriers of the A/G-G/G allelic combination of the c.2039 A>G and c.-29 G>A FSH receptor polymorphisms retrieve the highest number of oocytes in IVF/ICSI cycles.

Authors:  Adolfo Allegra; Angelo Marino; Stefania Raimondo; Antonio Maiorana; Salvatore Gullo; Piero Scaglione; Aldo Volpes; Riccardo Alessandro
Journal:  J Assist Reprod Genet       Date:  2016-11-05       Impact factor: 3.412

3.  An in silico model using prognostic genetic factors for ovarian response in controlled ovarian stimulation: A systematic review.

Authors:  B S Eisele; G C Villalba Silva; C Bessow; R Donato; V K Genro; J S Cunha-Filho
Journal:  J Assist Reprod Genet       Date:  2021-03-31       Impact factor: 3.357

4.  Investigation of the FSHR, CYP11, and INSR Mutations and Polymorphisms in Iranian Infertile Women with Polycystic Ovary Syndrome (PCOS).

Authors:  Elaheh Seyed Abutorabi; Batool Hossein Rashidi; Shiva Irani; Fedyeh Haghollahi; Maryam Bagheri
Journal:  Rep Biochem Mol Biol       Date:  2021-01

5.  Evaluating influence of the genotypes in the follicle-stimulating hormone receptor (FSHR) Ser680Asn (rs6166) polymorphism on poor and hyper-responders to ovarian stimulation: a meta-analysis.

Authors:  Noel Pabalan; Camila Martins Trevisan; Carla Peluso; Hamdi Jarjanazi; Denise Maria Christofolini; Caio Parente Barbosa; Bianca Bianco
Journal:  J Ovarian Res       Date:  2014-12-20       Impact factor: 4.234

6.  Relationship Between Genotype Variants Follicle-stimulating Hormone Receptor Gene Polymorphisms (FSHR) and Morphology of Oocytes Prior to ICSI Procedures.

Authors:  Zafer Gashi; Shkelzen Elezaj; Afrim Zeqiraj; Driton Grabanica; Isak Shabani; Bujar Gruda; Fitore Gashi
Journal:  Med Arch       Date:  2016-10-25

7.  Profile of follicle-stimulating hormone and polymorphism of follicle-stimulating hormone receptor in Madrasin cattle with ovarian hypofunction.

Authors:  Budi Utomo; Emmanuel Djoko Putranto; Amaq Fadholly
Journal:  Vet World       Date:  2020-05-11

8.  Association of single-nucleotide polymorphisms in the ESR2 and FSHR genes with poor ovarian response in infertile Jordanian women.

Authors:  Amer Mahmoud Sindiani; Osamah Batiha; Esra'a Al-Zoubi; Sara Khadrawi; Ghadeer Alsoukhni; Ayesha Alkofahi; Nour Alhoda Alahmad; Sherin Shaaban; Eman Alshdaifat; Masood Abu-Halima
Journal:  Clin Exp Reprod Med       Date:  2021-01-28

Review 9.  Perspectives on the development and future of oocyte IVM in clinical practice.

Authors:  Michel De Vos; Michaël Grynberg; Tuong M Ho; Ye Yuan; David F Albertini; Robert B Gilchrist
Journal:  J Assist Reprod Genet       Date:  2021-07-03       Impact factor: 3.412

10.  Frequency of the T307A, N680S, and -29G>A single-nucleotide polymorphisms in the follicle-stimulating hormone receptor in Mexican subjects of Hispanic ancestry.

Authors:  Gabriela García-Jiménez; Teresa Zariñán; Rocío Rodríguez-Valentín; Nancy R Mejía-Domínguez; Rubén Gutiérrez-Sagal; Georgina Hernández-Montes; Armando Tovar; Fabián Arechavaleta-Velasco; Patricia Canto; Julio Granados; Hortensia Moreno-Macias; Teresa Tusié-Luna; Antonio Pellicer; Alfredo Ulloa-Aguirre
Journal:  Reprod Biol Endocrinol       Date:  2018-10-19       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.